How Brazilian Chiropractors Are Facing the COVID-19 Pandemic
How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic
Brazil has the Latin America's largest coronavirus outbreak, numbers second only to the United States in the western hemisphere. The first COVID-19 confirmed case in Brazil was on February of 2020. A 61yrs old man tested positive after returning from a trip to Italy. Few other very first cases were also imported from Europe by returning travelers. The first locally transmitted case was registered on March of 2020, when a total of 8 cases have already been confirmed. At the time the WHO declares the outbreak as a pandemic (March 11) Brazil had 52 confirmed cases being 6 of those locally transmitted.
Healthcare professionals are now more important than ever. Given the intrinsic nature of the hands-on treatment of the Chiropractic profession, it is extremely important to understand what strategies chiropractors have put in place to address patient care, safety, and self report COVID contamination of those professionals.
調査の概要
研究の種類
入学 (予想される)
連絡先と場所
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Chiropractors graduated from national or international accredited colleges.
Exclusion Criteria:
- Chiropractors who did not treated patients in 2020.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Brazilian chiropractors
A cross-sectional survey will be performed with this population (Brazilian chiropractors) to assess outcomes regarding what is the current impact and what measures they have implemented while facing the COVID-19 pandemic.
|
Brazilian chiropractors will be invited by email and social media to answer an electronic survey.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
What measures have been implemented to avoid SARS-COV2 transmission when taking care of patients, during the COVID-19 pandemic.
時間枠：2 weeks
|
Subjects will answer a online survey addressing what measures they have implemented to prevent SARS-COV2 contamination among staff and patients, when taking care of patients.
These questions address the use of individual protection devices, sanitizing methods, social distancing, patient orientation, and consultation time.
These will be analyzed in conjunct, using descriptive statistics.
|
2 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Professionals SARS-COV2 infection rates.
時間枠：2 weeks
|
Self declared SARS-COV2 infection rates.
|
2 weeks
|
|
Professional financial impact.
時間枠：2 weeks
|
To assess the potential professional financial impact caused by the pandemic, the subjects will answer a question in the survey addressing if they have had a financial loss during the pandemic.
This question will have the following answer options: no financial loss, less than 25% financial loss, between 25-50%, between 50-75%, more than 75% of financial loss due the pandemic.
|
2 weeks
|
協力者と研究者
捜査官
- 主任研究者：MARCELO B BOTELHO, DC, MD, MSc、Trate
研究記録日
主要日程の研究
研究開始 (予想される)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- TrateTE
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
COVID19の臨床試験
-
Israel Institute for Biological Research (IIBR)完了
-
Colgate Palmolive完了
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., Ltd積極的、募集していない
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital Zürich招待による登録